zanamivir has been researched along with Fever in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.55) | 18.2507 |
2000's | 6 (27.27) | 29.6817 |
2010's | 14 (63.64) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Bando, T; Chong, Y; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Shindo, S; Takasaki, Y; Tani, N | 1 |
Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N | 3 |
Ikematsu, H; Ishikawa, Y; Iwaki, N; Kashiwagi, S; Kawai, N; Shiosakai, K; Yamaguchi, H | 1 |
Ariga, T; Ishiguro, N; Kaiho, M; Kikuta, H; Koseki, N; Oba, K; Togashi, T | 1 |
Bamba, M; Ichikawa, M; Ide, Y; Kawakami, C; Kawaoka, Y; Mitamura, K; Sakai-Tagawa, Y; Sugaya, N; Yamaguchi, Y; Yamazaki, M; Yasuhara, R | 1 |
Ichikawa, M; Kawakami, C; Kawaoka, Y; Mitamura, K; Sugaya, N; Tamura, D; Yamazaki, M | 1 |
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S | 1 |
Baranovich, T; Dapat, C; Dapat, IC; Ishitani, N; Matsuda, R; Oguma, T; Saito, R; Sato, I; Suzuki, H; Suzuki, Y; Zaraket, H | 1 |
Bilgin, H; Odabas, D; Sert, A; Yazar, A | 1 |
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Maeda, T; Matsuura, S; Nishimura, M; Tanaka, O; Yamauchi, S | 1 |
Ajisaka, K; Ikematsu, H; Kashiwagi, K; Kashiwagi, S; Masui, S; Nabeshima, S; Takeoka, H | 1 |
Ito, H; Katsumi, Y; Kidowaki, S; Matsui, F; Mibayashi, A; Otabe, O; Tsuma, Y | 1 |
Hirotsu, N; Ikematsu, H; Iwaki, N; Kashiwagi, S; Kawai, N; Kawashima, T; Maeda, T; Ukai, H | 1 |
Blanchon, T; Carrat, F; Duval, X; Flahault, A; Leport, C; Mentré, F; Mosnier, A; Tibi, A; Tubach, F; Van der Werf, S | 1 |
Kashiwagi, S; Mitsui, N; Shiosakai, K; Shiozawa, T; Tanigawa, M; Yamaguchi, F; Yamaguchi, H; Yamanouchi, N; Yoshida, S | 1 |
Schmidt, RE | 1 |
Monto, AS; Ohmit, SE | 1 |
Hirotsu, N; Horii, S; Ikematsu, H; Iwaki, N; Kanazawa, H; Kashiwagi, S; Kawai, N; Kawamura, K; Kawashima, T; Maeda, T; Nagai, T; Tanaka, O; Yamauchi, S | 1 |
Keene, O; Monto, AS; Webster, A | 1 |
Colopy, M; Elliott, M; Gravenstein, S; Monto, AS; Schweinle, J | 1 |
8 trial(s) available for zanamivir and Fever
Article | Year |
---|---|
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antiviral Agents; Child; Enzyme Inhibitors; Female; Fever; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Neuraminidase; Pregnancy; Product Surveillance, Postmarketing; Pyrans; Sialic Acids; Treatment Outcome; Young Adult; Zanamivir | 2017 |
The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011-2012 influenza season.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Female; Fever; Guanidines; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Pyrans; Sialic Acids; Young Adult; Zanamivir | 2014 |
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
Topics: Adult; Antiviral Agents; Cytokines; Drugs, Chinese Herbal; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Statistics, Nonparametric; Treatment Outcome; Zanamivir | 2012 |
Effect of a single inhalation of laninamivir octanoate in children with influenza.
Topics: Administration, Inhalation; Adolescent; Child; Child, Preschool; Female; Fever; Guanidines; Humans; Influenza, Human; Male; Neuraminidase; Pyrans; Sialic Acids; Surveys and Questionnaires; Treatment Outcome; Zanamivir | 2012 |
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cough; Drug Therapy, Combination; Enzyme Inhibitors; Family Characteristics; Female; Fever; Follow-Up Studies; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Oseltamivir; Time Factors; Young Adult; Zanamivir | 2012 |
Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
Topics: Antiviral Agents; Drug Tolerance; Fever; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Pharyngitis; Pyrans; Respiratory Tract Infections; Risk; Seasons; Sialic Acids; Treatment Outcome; Zanamivir | 2002 |
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Treatment Outcome; Zanamivir | 2008 |
Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.
Topics: Antiviral Agents; Double-Blind Method; Fever; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Nebulizers and Vaporizers; Prospective Studies; Pyrans; Sialic Acids; Zanamivir | 1999 |
14 other study(ies) available for zanamivir and Fever
Article | Year |
---|---|
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons.
Topics: Antiviral Agents; Fever; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Japan; Neuraminidase; Pyrans; Seasons; Sialic Acids; Zanamivir | 2022 |
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Female; Fever; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Pyrans; Seasons; Sialic Acids; Young Adult; Zanamivir | 2018 |
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 season.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Chromatography, Affinity; Female; Fever; Guanidines; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Male; Prospective Studies; Pyrans; Sialic Acids; Time Factors; Treatment Outcome; Zanamivir | 2014 |
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Topics: Acids, Carbocyclic; Antiviral Agents; Child; Child, Preschool; Cyclopentanes; Enzyme Inhibitors; Female; Fever; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pyrans; Severity of Illness Index; Sialic Acids; Time Factors; Treatment Outcome; Viral Proteins; Virus Shedding; Zanamivir | 2015 |
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015.
Topics: Administration, Inhalation; Antiviral Agents; Child; Female; Fever; Guanidines; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Japan; Kaplan-Meier Estimate; Male; Product Surveillance, Postmarketing; Proportional Hazards Models; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir | 2016 |
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Oseltamivir; Retrospective Studies; Treatment Outcome; Zanamivir | 2008 |
Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Mutation; Neuraminidase; Oseltamivir; Time Factors; Zanamivir | 2009 |
Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Topics: Adolescent; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Fever; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Microbial Sensitivity Tests; Mutation, Missense; Nasopharynx; Neuraminidase; Oseltamivir; Treatment Outcome; Viral Proteins; Zanamivir | 2010 |
An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Topics: Antiviral Agents; Fever; Gentamicins; Humans; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Zanamivir | 2010 |
Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
Topics: Adolescent; Adult; Antiviral Agents; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pandemics; Seasons; Young Adult; Zanamivir | 2011 |
Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Enzyme Inhibitors; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Inhibitory Concentration 50; Male; Middle Aged; Neuraminidase; Oseltamivir; Seasons; Severity of Illness Index; Treatment Outcome; Young Adult; Zanamivir | 2013 |
Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Child; Female; Fever; Guanidines; Humans; Influenza, Human; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Neuraminidase; Product Surveillance, Postmarketing; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir | 2013 |
Symptomatic predictors of influenza virus positivity in children during the influenza season.
Topics: Acetamides; Aging; Antiviral Agents; Child; Child, Preschool; Cough; Fever; Guanidines; Headache; Humans; Infant; Influenza, Human; Logistic Models; Muscular Diseases; Odds Ratio; Oseltamivir; Pyrans; Risk Factors; Seasons; Sialic Acids; Zanamivir | 2006 |
Clinical signs and symptoms predicting influenza infection.
Topics: Adolescent; Adult; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cough; Diagnosis, Differential; Double-Blind Method; Female; Fever; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Pharyngitis; Predictive Value of Tests; Pyrans; Retrospective Studies; Sialic Acids; Time Factors; Zanamivir | 2000 |